Richard E. Kaufman, Senior VP& Chief Operating Officer at Intersect ENT, Inc. (XENT), sold 958 shares at $37.21 ($36K) on 2018-02-01, disclosed to the SEC on 2018-02-05.
Scheduled sale ($36k) by Senior VP& Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XENT | SELL | 2017-09-27 | $790K | — | Filing → |
| XENT | SELL | 2017-08-29 | $678K | — | Filing → |
| XENT | SELL | 2017-07-26 | $353K | — | Filing → |